DK Pierce

DK Pierce (DKP) has been blazing trails in market access and reimbursement for over two decades. We provide strategic and tactical services spanning entire product lifecycles with a focus on oncology, rare diseases, and cell and gene therapies. Our seasoned specialists excel at anticipating, monitoring, and effectively interpreting the biopharma space. As a nimble, employee-owned company, DKP offers unparalleled expertise with an unexpected personal touch. From our clients, team, and partners, to the patients we want to see thrive, were a people-first consulting firm. Partnering with us means partnering with true specialistsnot generalistswho dig deep and provide trusted guidance and...

Oncology,physician administered drugs,managed markets,compendia strategy,gene therapy,market research,market access,cell therapy,self-administered drugs,medical benefit,reimbursement,commercial payers,medicaid,medicare,business intelligence,market monitoring,rare disease,and women-owned

Dk pierce operates in the Business consulting and services industry.

Dk pierce's revenue is 11m - 100m

Dk pierce has 11 - 50 employees.